ClinConnect ClinConnect Logo
Search / Trial NCT06210789

Periodontal Plastic Reconstruction of Soft Tissue Dehiscences After the Removal of Localized Gingival Enlargements

Launched by SEMMELWEIS UNIVERSITY · Jan 8, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Periodontal Reconstructive Surgery Surgical Excision Surgical Treatment Localized Gingival Enlargement

ClinConnect Summary

This clinical trial is studying a surgical method to treat localized gum enlargements and the associated gum recession in adults. Specifically, it aims to find an effective way to remove the enlarged gum tissue while also addressing the resulting gum recession, which can make it difficult to maintain good oral hygiene. This is important because if these issues are not resolved, they may lead to further gum problems. The study combines different surgical techniques to achieve better results for patients.

To be eligible for this trial, participants must be at least 18 years old and generally healthy, with localized gum enlargement affecting no more than three teeth. Unfortunately, pregnant women, heavy smokers, and those taking certain medications that could affect healing won't be able to participate. If you join the study, you can expect to undergo a surgical procedure aimed at improving both the appearance and health of your gums, and the trial is currently recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients older than 18 years
  • systematically healthy patients
  • localized gingival enlargement is present that involves maximum 3 teeth
  • Exclusion Criteria:
  • pregnant women
  • medication intake that can potentially affect the oral mucosa and its healing
  • heavy smokers (\>=15)

About Semmelweis University

Semmelweis University, located in Budapest, Hungary, is a prestigious institution renowned for its commitment to advancing medical education, research, and healthcare innovation. As a prominent clinical trial sponsor, the university leverages its extensive expertise in various medical fields to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing therapeutic strategies. With a focus on ethical standards and scientific excellence, Semmelweis University collaborates with a network of healthcare professionals and researchers to translate groundbreaking discoveries into practical applications, ultimately contributing to the global advancement of medical science.

Locations

Budapest, , Hungary

Patients applied

0 patients applied

Trial Officials

Bálint Molnár

Principal Investigator

Semmelweis University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported